US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Jennifer Garner dropped by the house her ex-husband, Ben Affleck, has been staying alone in amid rum2024-05-21
European Union official urges G7 to step up air defense for Ukraine and expand Iran sanctions
CAPRI, Italy (AP) — The European Union’s top diplomat urged Group of Seven foreign ministers on Thur2024-05-21Under mounting pressure, Biden opts to press for ceasefire in Gaza
The U.S. government has been facing increasing protests across the country calling for a ceasefire i2024-05-21One in THREE people will be struck down with 'silent killer' amid huge surge in condition
One in three people will develop an irregular heartbeat in their life-time, research suggests. Atria2024-05-21Cannes 2024: Studio Ghibli takes a bow with an honorary Palme d'Or
CANNES, France (AP) — Studio Ghibli, the Japanese anime factory of surreal ecological wonders that h2024-05-21UK's Prince William returns to public duties for first time since Kate's cancer diagnosis
LONDON (AP) — Prince William returns to public duties on Thursday for the first time since his wife’2024-05-21
atest comment